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a b s t r a c t
The connection of the coronary vasculature to the aorta is one of the last essential steps of cardiac
development. However, little is known about the signaling events that promote normal coronary artery
formation. The bone morphogenetic protein (BMP) signaling pathway regulates multiple aspects of
endothelial cell biology but has not been speciﬁcally implicated in coronary vascular development. BMP
signaling is tightly regulated by numerous factors, including BMP-binding endothelial cell precursor-
derived regulator (BMPER), which can both promote and repress BMP signaling activity. In the embryonic
heart, BMPER expression is limited to the endothelial cells and the endothelial-derived cushions,
suggesting that BMPER may play a role in coronary vascular development. Histological analysis of
BMPER/ embryos at early embryonic stages demonstrates that commencement of coronary plexus
differentiation is normal and that endothelial apoptosis and cell proliferation are unaffected in
BMPER/ embryos compared with wild-type embryos. However, analysis between embryonic days
15.5–17.5 reveals that, in BMPER/ embryos, coronary arteries are either atretic or connected distal to
the semilunar valves. In vitro tubulogenesis assays indicate that isolated BMPER/ endothelial cells
have impaired tube formation and migratory ability compared with wild-type endothelial cells,
suggesting that these defects may lead to the observed coronary artery anomalies seen in BMPER/
embryos. Additionally, recombinant BMPER promotes wild-type ventricular endothelial migration in a
dose-dependent manner, with a low concentration promoting and high concentrations inhibiting
migration. Together, these results indicate that BMPER-regulated BMP signaling is critical for coronary
plexus remodeling and normal coronary artery development.
& 2013 Elsevier Inc. All rights reserved.
Introduction
During early heart development, simple diffusion of blood is
sufﬁcient to supply the heart with nutrients and oxygen. As the
heart remodels, however, the coronary vasculature must develop
to support the oxygen and nutrient needs of a larger, more
muscular heart. A wide range of coronary anomalies have been
documented, consisting of both severe (a failure of the coronary
vasculature to connect to the aorta) and less severe (abnormal
locations and numbers of coronary stems and irregular branching
patterns) anomalies (Angelini, 2002). It comes as no surprise that
the absence of both coronary arteries has clearly deleterious
effects on the developing organism; however, even less severe
anomalies can lead to sudden death (Maron, 2003; Turkmen et al.,
2007), illustrating the need for a comprehensive understanding of
the mechanisms and pathways involved in the development of the
coronary vasculature.
The coronary vasculature begins forming before the heart has
fully septated and connects to the aorta long after the heart has
begun beating (Bernanke and Velkey, 2002). The coronary vascu-
lature begins as a plexus of endothelial cells that spread from the
sinus venosus to encompass the ventricles (Lavine et al., 2006;
Red-Horse et al., 2010). These endothelial cells derive from the
proepicardium and traverse through the sinus venosus to yield the
subepicardial venous plexus and the intramyocardial arterial
plexus (Red-Horse et al., 2010; Katz et al., 2012; Wu et al., 2012;
Tian et al., 2013). This initial network remodels to form a more
mature pattern comprising arteries and veins, with a number of
small vessels initially connecting to the aorta and coalescing to
form two distinct ostia or openings (Ando et al., 2004; Pérez-
Pomares and de la Pompa, 2011). In addition to the endothelial
cells that form the coronary plexus, smooth muscle cells derived
from the proepicardium surround and support the portion of
the coronary artery that connects with the aorta, known as the
coronary stem (Gittenberger-de Groot et al., 1999; von Kodolitsch
et al., 2004; Grieskamp et al., 2011). Even though the overall
progression of coronary vascular development has been well
documented (Riley and Smart, 2011), key gaps remain in our
understanding of this process, particularly with respect to the
signaling cues that guide endothelial cell migration.
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/developmentalbiology
Developmental Biology
0012-1606/$ - see front matter & 2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ydbio.2013.12.019
n Correspondence to: Division of Cardiology and UNC McAllister Heart Institute
8200 Medical Biomolecular Research Building Chapel Hill, NC 27599-7126, USA.
Fax: þ1 919 843 4585.
E-mail address: cpatters@med.unc.edu (C. Patterson).
Developmental Biology 386 (2014) 385–394
One signaling pathway that is important in endothelial cell
biology is the bone morphogenic protein (BMP) pathway.
Endothelial cells express a range of BMPs, including BMPs 2, 4, 6,
and 7, as well as type 1 and 2 BMP receptors (Bobik, 2006). The
effects of the BMPs on endothelial cell function are highly context
dependent, with a single BMP being capable of signaling through
multiple intracellular pathways. BMPs can stimulate cell migra-
tion, angiogenesis, apoptosis, and proliferation in some settings
yet inhibit proliferation and apoptosis in others (Bobik, 2006;
Wiley and Jin, 2011). The BMP signaling pathway is complex and
regulated at many different levels. One level of regulation is
afforded by extracellular BMP regulators such as chordin, noggin
and BMPER (BMP-binding endothelial cell precursor-derived reg-
ulator). Whereas most of these regulators behave as either a
repressor or inducer of BMP signaling, BMPER can act as both
(Kelley et al., 2009). In vivo, BMPER has pro-BMP roles in the
mouse eye, kidney, and skeleton (Ikeya et al., 2006); zebraﬁsh
gastrulation (Rentzsch et al., 2006) and axis formation (Moser
et al., 2007); and drosophila crossvein formation (Conley et al.,
2000). However, BMPER has also been attributed anti-BMP roles in
mouse retinal vascularization (Conley et al., 2000; Moreno-
Miralles et al., 2011) and Xenopus axis formation (Moser et al.,
2003). In vitro, BMPER has been ascribed a pro-BMP role and
promotes sprouting and migration in human umbilical vein
endothelial cells (HUVECs) (Heinke et al., 2008).
Despite the well-documented effects of the BMP pathway on
endothelial cell biology, its role in coronary vascular development
has yet to be demonstrated. Therefore, this study was undertaken
to explore the role that BMP and its extracellular regulator BMPER
has on the development of the coronary vasculature. We hypothe-
sized that BMPER would regulate BMP signaling to promote
coronary vascular development and tested this theory using the
BMPER/ embryo as our model system. Embryonic BMPER /
hearts present with a range of coronary anomalies, despite a
normal initiation of coronary plexus formation. Further, endothe-
lial apoptosis and subsequent contributions from the proepicar-
dium appear normal in the BMPER / hearts when compared
with wild-type hearts. Analysis of ventricular endothelial cells
isolated during coronary vascular remodeling reveal that BMPER /
endothelial cells have impaired migration and remodeling abilities
compared with their wild-type counterparts. In addition, recombi-
nant BMPER promotes wild-type ventricular endothelial migration in
a dose-dependent manner, with a low concentration promoting and
high concentrations inhibiting migration. Together, these results
indicate that BMPER-induced BMP signaling promotes normal cor-
onary vascular development and that BMP signaling is critical for
normal coronary stem formation.
Materials and methods
Mice
The creation of the BMPER / mouse was previously described
(Kelley et al., 2009). Mice were maintained on a C57BL/6N/129
background. Because the BMPER/ embryo exhibits perinatal
lethality (Kelley et al., 2009), timed matings were performed using
BMPERþ / mice. All experiments were approved by the Institu-
tional Animal Care and Use Committee at the University of North
Carolina at Chapel Hill. Based on the frequency of the coronary
defects, eight BMPER/ embryos were required for each experi-
ment that compared wild-type and BMPER / embryos to have
sufﬁcient statistical power (power calculations: α¼0.05, 95%
conﬁdence, size effect¼0.67 based on coronary defects). Thus,
the in vivo quantitative analyses have a minimum of eight
embryos per group.
Histology
For immunohistochemical analyses, E12.5–E16.5 embryos were
harvested in phosphate-buffered saline (PBS), ﬁxed in 4% formal-
dehyde overnight at 4 1C, washed in PBS, and processed for
parafﬁn or frozen sectioning, performed by the Histology Research
Core Facility at UNC. Additional hearts were harvested and utilized
for whole-mount immunohistochemistry. Unless indicated, immu-
nohistochemistry was performed as previously described (Waldo
et al., 1996). Primary antibodies included MF-20 (Developmental
Studies Hybridoma Bank, Iowa City, IA, USA), PECAM (Becton-
Dickinson, San Jose, CA, USA), phospho-Smad1, 5, 8 (pSmad; Cell
Signaling Technology, Danvers, MA, USA), phospho-Erk1/2 (Cell
Signaling Technology), anti-Crossveinless-2 (also known as
BMPER, R&D Systems, Minneapolis, MN, USA), and α-smooth
muscle actin (Sigma-Aldrich, St. Louis, MO, USA). Primary anti-
bodies were detected using species-speciﬁc Alexa Fluor antibodies
(Invitrogen, Grand Island, NY, USA) or ABC Elite kits and diamino-
benzidine (Vector Labs, Burlingame, CA, USA). pSmad and pERK
immunohistochemistry was performed as described in Dyer et al.
(2010) with the addition of 1% BSA to the block solution for pERK,
and BMPER immunohistochemistry was performed as previously
described (Zakin et al., 2008). For whole-mount confocal micro-
scopy, hearts were dehydrated and cleared with methyl salicylate
prior to visualization.
In situ hybridization
The Tbx18 probe was kindly provided by Dr. Andreas Kispert
(Medizinische Hochschule Hannover, Germany). In brief, embryos
were collected and processed for frozen sectioning under RNase-
free conditions. In situ hybridization was performed on 5-mm
sections by the In Situ Hybridization Core Facility at UNC.
Microscopy and image processing
All microscopy was performed in conjunction with the Micro-
scope Services Laboratory at UNC. Sections were imaged using an
Olympus BX61 upright ﬂuorescence microscope, and whole hearts
were imaged using a Zeiss LSM5 Pascal confocal laser scanning
microscope for ﬂuorescently labeled hearts or a Leica-Wild M420
Macroscope for diaminobenzidine-labeled hearts. Live cell
imaging was performed using an Olympus IX70 inverted ﬂuores-
cence microscope that was ﬁtted with a humidiﬁed, temperature-
controlled chamber that was maintained at 5% CO2. Volocity
software was used to obtain all images. Static images were
processed using Adobe Photoshop, and confocal image stacks
were processed with Imaris. To compare phosphorylated protein
expression, all acquisition parameters were identical when photo-
graphing the slides and processing the images to ensure that any
differences in expression levels were real. Fluorescence intensity
was assessed using the histogram tool, and the intensity in the
BMPER / embryos was assessed as the fold change with respect
to the average intensity of the wild-type embryos in each
individual litter to account for inter-litter variability and to mini-
mize other processing-related variables, such as time between
immunohistochemistry and visualization.
Immunoblots
The aortic valves of E13.5 and E14.5 wild-type and BMPER /
embryos were excised, harvested in ice-cold lysis buffer containing
phosphatase inhibitors, and homogenized using TissueLyser LT
(Qiagen, Valencia, CA) (Meng et al., 2008). Each sample comprises
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four individual valves. Membranes were blotted for pSmad and β-
actin as a loading control. Band density was quantiﬁed in ImageJ
(www.nih.gov) and is presented as the percentage of the wild-type
pSmad/β-actin ratio.
Endothelial cell isolation
Endothelial cells were isolated from the ventricles of embryo-
nic day 14.5–16.5 mice as recently described (Dyer and Patterson,
2013a). In brief, ventricles were isolated from the embryos, minced
gently, and digested in collagenase type I for 45 min at 37 1C with
gentle agitation. The resulting cell suspensionwas washed twice in
DMEM (Gibco, Grand Island, NY, USA) containing 10% fetal bovine
serum (FBS, Sigma-Aldrich) prior to an incubation with anti-
PECAM-conjugated Dynabeads (Invitrogen), prepared according
to the manufacturer0s recommendations. PECAM is expressed by
both coronary endothelial cells and endocardial cells. However,
contributions from the ventricular endocardium to the coronary
endothelium primarily occur at E11.5, with endocardial migration
decreasing dramatically thereafter (Zhang and Zhou, 2013); thus,
all migratory cells at the assessed time points are considered
coronary endothelial cells, and all samples should be similarly
affected by non-migratory endocardial cells. After a 30 min incu-
bation at 4 1C, the bead–cell solution was washed ﬁve times with
10% FBS–DMEM and once with DMEM prior to dissociating the
cells from the beads using trypsin–EDTA (Gibco). The resulting
cells were pelleted and resuspended as follows. For live cell
imaging of the tube formation assay, cells were resuspended in
endothelial cell growth medium (ECGM) (DMEM containing 20%
FBS, 5 mM β-mercaptoethanol, 50 mg/ml ECG (Biomedical Technol-
ogies, Inc., Stoughton, MA, USA), and penicillin/streptomycin)
and plated on collagen-coated plates. Plates were prepared as
described in Runyan and Markwald (1983); all endothelial cells
remained on the surface of this collagen gel and preferred
migrating on this collagen gel compared with a simple coat of
collagen (Dyer and Patterson, 2013a). The number of cells per well
was counted after plating to ensure that similar numbers of cells
were analyzed. For transwell assays, endothelial cells were resus-
pended in DMEM and placed in the upper chamber of a transwell
(Corning, 8.0 μm pore size, polycarbonate membrane).
Endothelial cell analysis – tube formation assay
Approximately 24 h after plating, isolated endothelial cells
were incubated with the ﬂuorescent marker Syto-16 (Invitrogen),
which is highly enriched in endothelial cells (Arima et al., 2011).
After 1 h, the medium was replaced with fresh ECGM, and time-
lapse photography was performed. Isolated cells were maintained
in a humidiﬁed chamber at 37 1C with 5% CO2 and were imaged
every 15 min for 22 h. The resulting movies were analyzed with
the MTrack plugin (Meijering, Dzyubachyk (Smal)) for ImageJ
(rsbweb.nih.gov/ij/). The following parameters were analyzed:
migration distance, cell–cell interactions, chain length, and chain
branching. For migration distance, the ﬁve most motile cells per
sample were tracked. Embryos were not genotyped until the
analyses were complete to prevent biasing the results.
Endothelial cell analysis – transwell migration assay
For transwell migration analysis, wild-type isolated endothelial
cells were resuspended in DMEM (approximately 2,000 cells per
75 μl DMEM). DMEM (500 μl) was added to the lower chamber,
and the cells were given one hour at 37 1C to settle. Vehicle control
or recombinant BMPER (10–75 ng/ml) was added to the lower
chamber, and endothelial cells were allowed to migrate for four
hours at 37 1C. VEGF was used as a positive control. After 4 h, the
upper chamber side of the membrane was swabbed gently with a
cotton-tipped applicator, and the membranes were incubated in
0.1% crystal violet for 1 h (Mandelboim, 2006). The membranes
were thoroughly washed with distilled water, and four 10
images were obtained for each membrane. For each experiment,
equal cell numbers were plated in controls and treated wells, and
the results are presented as the fold change compared with the
control to account for slight variability between experiments.
Ex vivo BMPER-conjugated bead treatments
Hearts were excised from E13.5 embryos and cultured as
previously described (Dyer and Patterson 2013b). Agarose beads
were conjugated to BMPER (72 ng/μl) or vehicle control as
described in Bronner-Fraser (2008) and placed adjacent to the
ventricles, tucked near the outﬂow tract. Hearts were cultured
ex vivo with beads for 24 h. Hearts were then ﬁxed, the position of
the bead was documented, and hearts were prepared for immu-
nohistochemistry for pSmad and PECAM to determine how BMP
signaling and endothelial recruitment were affected by
exogenous BMPER.
Statistics
For the migratory data and ﬂuorescent intensity comparisons,
ANOVA and unpaired Student0s t-tests with equal variances were
performed in Excel. Results are presented as the mean and s.e.m.
For categorical data, comparisons were analyzed using Fisher0s
exact test in R. A p-value o0.05 was considered signiﬁcant.
Results
BMPER is expressed in cardiac endothelial cells and endothelial cell
derivatives
Because BMPER was discovered in endothelial cell precursors
(Moser et al., 2003) and BMPER mRNA is expressed in the
zebraﬁsh vasculature (Moser et al., 2007), we evaluated BMPER
protein expression in the murine heart using immunohistochem-
istry. At E12.5–E14.5, BMPER was expressed in the outﬂow tract
cushions and subsequent valve leaﬂets but was not expressed
within the overlying endothelial layer (Fig. 1A, B, D–H). BMPER
expression did not colocalize with the myocardium, and DAPI-
positive, BMPER-negative endocardial cells are observed in the
outﬂow tract cushions (Fig. 1A). BMPER0s expression in the
endocardial cells lining the trabeculae (Fig. 1A) appears to corre-
late with PECAM (Fig. 1B). Importantly, BMPER protein is not
detected in BMPER / embryos (Fig. 1C). BMPER-positive coron-
ary vessels were observed at the base of the outﬂow tract
myocardium (Fig. 1D–F). Interestingly, the coronary arteries did
not express BMPER during insertion into the aorta (Fig. 1G and H),
suggesting that BMPER must be downregulated in the coronary
endothelial cells prior to their connection with the aorta. The
expression of BMPER in a subset of coronary vessels prompted us
to examine whether BMPER plays a role in coronary plexus
development.
Coronary plexus formation begins normally in the BMPER / embryo
Because BMPER and the BMP signaling pathway have been
linked to the development of vascular networks in other models
(Moser et al., 2007; Moreno-Miralles et al., 2011; Pi et al., 2012),
coronary plexus development was examined in wild-type and
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BMPER/ hearts to determine whether BMPER is important for
the development of the coronary plexus. Whole mount immuno-
histochemical analysis of wild-type and BMPER/ hearts at E14.5
showed that PECAM-positive endothelial cells completely encom-
passed the ventricles from sinus venosus to apex (Fig. 2A, C, and E)
and were found within the compact myocardium of both wild-
type and BMPER / ventricles (Fig. 2B, D, and F). Based on the
whole mount immunohistochemistry, an analysis of the percen-
tage of the heart encompassed by the forming plexus, the number
of sprouts along the leading edge of the plexus, and the branch
points within the plexus showed no differences between geno-
types (Fig. 2G–I; see also Supplemental Fig. 1 for additional stages
and details showing the measured parameters). Thus, coronary
plexus formation occurs normally in the BMPER/ embryo.
Coronary stem formation is disrupted in the BMPER / embryo
By E15.5, the coronary vasculature should be connected to the
aorta via two distinct coronary ostia. Whole mount confocal
analysis of wild-type hearts between E15.5 and E17.5 demon-
strated normal connection of the coronary arteries to the aorta,
with the coronary arteries connecting to the aorta below the
semilunar valve, at the level of the myocardium (Fig. 3A–E).
However, analysis of BMPER / embryos at these stages of
development revealed varying degrees of malformation of the
coronary stems. In some BMPER / embryos (n¼5 of 18), the
coronary stems connected high above the semilunar valve, known
as a “high take-off coronary” (compare Fig. 3I with B). In such
cases, the high take-off coronary was observed up to 200 mm
above the semilunar valve, and the other coronary stem was
typically in the correct location (Fig. 3H, I). In other BMPER /
embryos, vessels were observed within the myocardium and even
the subepicardial space, but these vessels failed to connect to the
aorta (n¼9 of 18; Supplemental Fig. 2). These defects were
consistently observed in BMPER/ embryos; only rarely was a
coronary anomaly observed in wild-type embryos (n¼1 of 11
wild-type hearts; po0.001).
Because the C57BL/6N mouse strain is prone to high take-off
and atretic coronaries (Fernandez et al., 2008), we compared the
prevalence of defects in our mice to the reported prevalence of
coronary anomalies in pure C57BL/6N mice, and coronary atresia
was signiﬁcantly more prevalent (po0.01) in our BMPER /
embryos on the mixed background. Thus, the presence of the
C57BL/6N background in our mixed background does not explain
the BMPER / phenotype.
Coronary artery smooth muscle recruitment is not impaired in
BMPER / embryos
A ﬁnal step in coronary stem formation is the addition of
proepicardial-derived smooth muscle cells, which stabilize the
coronary stems (Gittenberger-de Groot et al., 1999). Because BMP
signaling promotes proepicardial addition (Schlueter et al., 2006;
Ishii et al., 2010), BMPER expression was analyzed in the proepi-
cardium at E9.5 to determine whether BMPER also affects proepi-
cardial derivatives. BMPER expression did not colocalize with the
proepicardial marker Tbx18, indicating that BMPER cannot directly
regulate proepicardial addition (Supplemental Fig. 3A and B).
Further, smooth muscle cells were recruited to the coronary stems
by E15.5 in BMPER/ embryos, as observed in wild-type
embryos, indicating that proepicardial derivatives are correctly
formed in the absence of BMPER (Supplemental Fig. 3C and D).
Together, these data indicate that BMPER does not affect the
proepicardium or its derivatives.
Fig. 1. BMPER is expressed in the endothelium and outﬂow tract cushions. Immunohistochemistry in saggital (A, B, D–F) and cross-sections (C, G, H) of E12.5 (A, B), E13.5 (D,
F, G) and E14.5 (E, H) wild-type embryos and (C) an E13.5 BMPER/ embryo demonstrates that BMPER expression is restricted to the outﬂow tract cushions and some
endothelial cells during outﬂow tract septation and coronary artery recruitment. (A, B) BMPER (black) does not colocalize with myocardial marker MF20 (red, A), is excluded
from the endocardial cells overlying the cushions (A), and shows a similar pattern in the ventricle as endothelial marker PECAM (green, B). (C) BMPER is not detected in the
aortic valve of an E13.5 BMPER/ embryo, highlighting the ﬁdelity of the antibody. (D, E) Low magniﬁcation images of the outﬂow tract of wild-type E13.5 (D) and E14.5
(E) embryos, including aorta (Ao) and pulmonary artery. (F–H) Higher magniﬁcation images highlight a BMPER-positive coronary vessel in the compact myocardium
(arrowhead, F) and BMPER expression in the aortic valve at E13.5 (G) and E14.5 (H); arrows indicate coronary stems. Ao, aorta; RV, right ventricle; PA, pulmonary artery; CA,
coronary artery. Blue, DAPI. Scale bar in A–E, 100 mm; scale bar in F, 25 μm; scale bar in G, H, 50 μm.
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BMPER / coronary endothelial cells do not undergo abnormal
proliferation or apoptosis
We next examined wild-type and BMPER/ hearts to determine
whether differences in endothelial cell proliferation or apoptosis may
be a potential mechanism responsible for the coronary stem defects
seen in the BMPER/ hearts, given BMP0s role in regulating
endothelial proliferation and apoptosis. In E12.5–E16.5 wild-type
and BMPER/ hearts, apoptotic endothelial cells were rarely
observed throughout the compact myocardium or speciﬁcally in
the coronary stems, and no differences were observed between
genotypes (Supplemental Fig. 4A–C). In addition, no difference in
endothelial cell proliferation was observed between wild-type and
BMPER/ hearts between E13.5 and E16.5 (Supplemental Fig. 4D–F).
Together, these data indicate that endothelial cell survival and
proliferation are not responsible for the observed coronary defects
seen in BMPER / hearts.
BMPER is required in a cell autonomous manner for coronary
endothelial migration
Based on BMPER0s expression pattern in the developing cor-
onary vasculature and the outﬂow tract cushions, we hypothesized
that BMPER may directly promote coronary endothelial migration
Fig. 2. The coronary plexus begins to form in the absence of BMPER. Whole mount immunohistochemistry in E14.5 wild-type (A) and BMPER/ (B) hearts shows that
endothelial cells (black) encompass the dorsal aspect of the ventricles and cover the ventricles by E14.5. Immunohistochemistry of sagittal sections of wild-type (C, E) and
BMPER / (D, F) hearts at E14.5 shows that this vasculature permeates the compact myocardium. Shown are low magniﬁcation (C, D) and higher magniﬁcation (E, F) images of
the left ventricle (LV) at the level of the mitral valve. Green, endothelium; blue, nuclei. To ensure that the vascular plexus developed normally in BMPER/ embryos, the
following measurements were compared in whole mount PECAM-labeled E14.5 hearts: the percentage of surface area encompassed by the plexus (G), the number of branch
points (H), and the number of sprouts in the leading edge of the plexus (I). No differences were oberved between genotypes. Scale bar in A, B, 500 mm; scale bar in C, D, 100 μm;
scale bar in E, F, 50 mm. Li, liver.
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or that BMPER may serve as a guidance cue to recruit coronary
endothelial cells to the aorta at the level of the aortic valve. Thus,
we ﬁrst performed in vitro assays to determine the effect of
BMPER speciﬁcally on coronary endothelial migration and tubu-
logenesis. Although siRNA is commonly used to assess the effects
of gene knockdown in cell culture, siRNA knockdown techniques
are typically not 100% efﬁcient (Dennstedt and Bryan, 2011).
BMPER0s effects on BMP signaling appear to be concentration-
dependent (Kelley et al., 2009), so a partial siRNA knockdown may
have unintended consequences. Thus, to truly assess the effects of
the absence of BMPER on endothelial cells, wild-type and
BMPER/ endothelial cells were isolated from the ventricles of
E14.5–16.5 embryos. These isolated cells labeled positively with
the endothelial markers isolectin, PECAM, Flk-1, and Syto-16
(Fig. 5A and Dyer and Patterson), conﬁrming the identity of the
isolated cells as endothelial cells and not supporting mural cells
(Arima et al., 2011). Isolated endothelial cells were plated on a
collagen gel and allowed to adhere for 24 h prior to live-cell
imaging. Due to the limited number of primary cells obtained,
traditional tubulogenesis assays were not possible. Instead, a 22-h
live-cell imaging period was used to document the cells0 behavior.
Wild-type endothelial cells migrated robustly, forming cell–cell
contacts that often led to chains with some branching (Fig. 4B and
C). In contrast, BMPER / endothelial cells migrated shorter
distances and tended to make fewer cell–cell contacts, which led
to shorter chains with little to no branching (Fig. 4B and C).
Further, BMPERþ / endothelial cells also display signiﬁcantly
reduced migration and fewer branches compared with wild-type
endothelial cells (Fig. 4B and C). These experiments demonstrate
that a speciﬁc dose of BMPER is required by ventricular endothelial
cells for migration and remodeling.
BMPER promotes canonical BMP signaling in the aortic valve
BMPER0s robust expression in the developing outﬂow tract
cushions during coronary artery recruitment suggested that
BMPER-mediated BMP signaling may affect coronary artery recruit-
ment by recruiting the coronary arteries to the aortic valve. Thus,
pSmad expression levels were examined in the valves at E13.5–E14.5.
These speciﬁc stages were examined because the coronary stems are
present by E14.0 (Compton et al., 2007). At E13.5, Smad was
phosphorylated in the valves of wild-type embryos (Fig. 5A), whereas
BMPER/ embryos appeared reduced Smad phosphorylation levels
(Fig. 5B). At E14.5, Smad phosphorylation remained high in the wild-
type valves (Fig. 5C) and reduced in the BMPER / valves (Fig. 5D).
These differences were conﬁrmed by performing immunoblot. The
Fig. 3. BMPER / embryos exhibit coronary stem defects. Whole mount confocal imaging of E17.5 wild-type (A–D) and BMPER/ (F–I) hearts through the aorta shows the
connection of the coronary arteries in a wild-type heart (arrows in A–D, depicted schematically in E) and in a BMPER / heart (arrows in F–I, depicted schematically in J). In
the BMPER / hearts, the coronary arteries either connect above the semilunar valve (arrow in H and I; n¼4 of 13 embryos) or fail to form stems at all (n¼7 of 13 embryos,
Supplemental Fig. 1). These defects are rarely observed in wild-type embryos (n¼1 of 9 embryos; po0.01). (E, I) Schematics depicting the insertion of the coronary artery in
the aortic sinuses; the schematic design is based on Clauss et al. (2006). Green, endothelium; red, myocardium. Ao, aorta. Scale bar, 150 mm.
Fig. 4. Migration is impaired in isolated BMPER/ ventricular endothelial cells. (A) Endothelial cells were isolated from E14.5-E16.5 wild-type (WT, n¼3), BMPERþ/
(n¼10), and BMPER/ (n¼3) ventricles with PECAM-conjugated beads. Wild-type isolated endothelial cells were positively labeled with lectin (red). Scale bar, 50 mm. After
24 h of culture, isolated endothelial cells were labeled with Syto-16 and photographed over a 20-h period. Compared with wild-type endothelial cells (black bars), BMPERþ/
 (gray bars) and BMPER/ (white bars) endothelial cells migrated less (B) and tended to create fewer cell–cell connections (p¼0.1, ANOVA) and branches (po0.05,
ANOVA) and shorter chains (measured as the number of cells per chain, po0.1, ANOVA) (C). npo0.05, nnpo0.01; Student0s t-test.
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aortic valve, together with the surrounding aortic wall, was dissected
from E13.5 and E14.5 wild-type and BMPER/ embryos, and four
embryos were pooled per sample. Compared with the wild-type
valves, Smad phosphorylation levels were down-regulated in the
BMPER / valves at both time points (Fig. 5E and F). By comparison,
Smad phosphorylation in the valve sinus endothelium was slightly
reduced in the BMPER/ embryos at both E13.5 and E14.5
compared with wild-type embryos, but this difference was not
signiﬁcant. Thus, the speciﬁc downregulation of Smad phosphoryla-
tion speciﬁcally within the BMPER / aortic valve may be associated
with the coronary artery insertion defects.
Although BMP signaling is most often associated with activation
of Smad, BMPs can also lead to ERK1/2 phosphorylation (Derynck
and Zhang, 2003). Therefore, ERK1/2 phosphorylation in the cardiac
valves was also compared between wild-type and BMPER / hearts
at E13.5–E14.5. However, at these stages of development, ERK1/2
phosphorylation was limited to the mesenchymal cells underlying
the tips of the valves in both wild-type and BMPER / embryonic
hearts (Supplemental Fig. 5). Thus, based on the discrete localization
of ERK1/2 phosphorylation, these results suggest that ERK1/2 signal-
ing does not affect coronary stem location.
BMPER may directly recruit coronary endothelial cells
Because BMPER is expressed in the aortic valve, at the level
where the coronary arteries are recruited to the aorta (Fig. 1),
where it promotes canonical BMP signaling (Fig. 5), we evaluated
whether BMPER could recruit coronary vessels in an ex vivo
culture system. Wild-type and BMPER/ E13.5 hearts were
excised and cultured in the presence of BMPER- or vehicle control-
conjugated agarose beads. Smad phosphorylation appeared to be
upregulated in cells adjacent to BMPER-conjugated beads in the
BMPER / hearts compared with control beads (Fig. 6A). Further, the
control beads appeared to have no effect on Smad phosphorylation in
both genotypes, and Smad phosphorylation appeared downregulated
in the BMPER / hearts with control beads compared with the wild-
type counterparts, consistent with Fig. 5. Consistent with a pro-
angiogenic role, BMPER-conjugated beads recruited PECAM-positive
endothelial cells in both wild-type and BMPER / hearts (Fig. 6B).
To determine whether BMPER directly promotes endothelial
migration, wild-type endothelial cells from E13.5 to 16.5 hearts
were used for transwell assays. BMPER doses were based on
previous work showing that BMPER can promote HUVEC migra-
tion (Heinke et al., 2008), and VEGF was used as a positive control
(Fig. 6C). Compared with vehicle control, the lowest dose of
BMPER (10 ng/ml) signiﬁcantly increased endothelial migration
1.6-fold over a 4-h period (Fig. 6D). Higher doses of BMPER (20–
75 ng/ml) decreased endothelial migration by one-third compared
with the vehicle control. This dose response suggests that a low
dose of BMPER can directly promote endothelial migration
whereas higher doses halt migration.
Discussion
The coronary vasculature is essential for late embryonic devel-
opment and post-natal life. However, whereas early stages of
coronary vascular development have been well described (Riley
and Smart, 2011), the crucial connection of the coronary plexus to
the aorta remains poorly understood. In the mouse in particular,
the process through which the stems are formed within the aorta
has not been clearly documented. This study takes advantage of
the BMPER / mouse model by beginning to unravel the distinct
steps required for normal coronary stem development. The
BMPER / mouse, which does not display early coronary plexus
defects, provides a unique opportunity to address the signaling
events required to recruit the coronary arteries to the aorta.
The BMP pathway has many known roles in endothelial cells,
where it can promote endothelial cell migration, proliferation, and
apoptosis (Wiley and Jin, 2011). Some of these speciﬁc roles have
been attributed to individual BMPs and particular intracellular
pathways. Speciﬁcally examining endothelial migration, BMP2 can
induce endothelial remodeling via p38/MAPK, through which it
modulates transcription factor Id1 (Raida et al., 2005), and possibly
via ERK1/2, though current studies are contradictory (Langenfeld
and Langenfeld, 2004; Raida et al., 2005). BMP4 can promote
endothelial migration via both the Smad and ERK intracellular
pathways (Heinke et al., 2008) and apoptosis through the Smad
Fig. 5. Canonical BMP activity is downregulated in BMPER/ aortic valves. Compared with wild-type aortic valves (A, C), BMP activity, as indicated by phosphorylated
Smad1, 5, 8 expression (pSmad, green), is downregulated in BMPER / aortic valves at E13.5 (B) and E14.5 (D). (E) The pSmad levels were quantiﬁed in aortic valves
dissected from E13.5 and E14.5 wild-type and BMPER/ embryos. Four valves were pooled in each lane, and pSmad band density, normalized to β-actin, is quantiﬁed in
(F) as the % of the age-matched wild-type sample. Red, endothelium, labeled with lectin. Arrows, aortic sinuses; arrowheads, coronary stems. Ao, aorta. Scale bar, 70 mm.
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and possibly Msx1/2 intracellular pathways (Kiyono and Shibuya,
2003). BMP6 can also promote endothelial migration via Id1
(Valdimarsdottir et al., 2002). Importantly within the context of
coronary stem formation, BMPs 2, 4, and 6 are expressed either
within the myocardium at the base of the aorta or in the aortic
endothelium and aortic valve leaﬂets during the establishment of
the coronary plexus and its subsequent connection with the aorta
(Kim et al., 2001; Jiao et al., 2003; Keyes et al., 2003; Liu et al., 2004;
Danesh et al., 2009; Jang et al., 2010). BMPER shows a similar
expression pattern, with expression within the endothelial cells
surrounding the outﬂow tract and within the endothelially derived
aortic valve mesenchyme. Thus, BMPER is spatiotemporally located
in a manner to regulate the BMPs that are being expressed. Further,
the dose-response migration data (Fig. 6D) suggest that increasing
concentrations of BMPER switch its role from acting as a pro-
migratory factor to an anti-migratory factor. A quantitative assess-
ment of the concentration of BMPER throughout the developing
heart would be interesting in that it may determine whether
BMPER0s expression level correlates with the dose-response migra-
tion data. However, without a reliable readout, for example, one
that is comparable to using Smad phosphorylation to assess
canonical BMP signaling, this experiment is not yet feasible.
Based on the expression of BMPs and BMPER and the known roles
of BMP signaling in endothelial behavior, the observed coronary stem
defects are not unexpected. However, coronary remodeling is poorly
studied. Endothelial cells are so heterogeneous that it is difﬁcult to
translate results from one speciﬁc endothelial cell population to
another (Dyer and Patterson, 2010), and embryonic coronary
endothelial cells are not currently commercially available. To further
complicate the study of BMPER in this population of cells, BMPER
itself shows a dose-dependent biphasic effect (Fig. 6 and Kelley et al.,
2009), rendering a partial siRNA knockdown model inadequate to
address what happens in the absence of BMPER. To truly analyze
coronary endothelial remodeling in vitro, speciﬁcally in the absence
of BMPER, coronary endothelial cells from the BMPER / embryo is
the ideal model.
Thus, we down-scaled well-established protocols for endothe-
lial cell isolation and applied them to the developing heart (Dyer
and Patterson). Preferably, these experiments would be performed
using cells isolated just prior to connection of the coronary
vasculature to the aorta; however, the yield of endothelial cells
obtained from such small hearts was insufﬁcient to perform the
desired analyses, even with the down-scaled assay we employed.
Instead, we utilized endothelial cells obtained from the hearts of
E14.5–16.5 embryos; these stages include the coronary remodeling
period (Lavine and Ornitz, 2009). Using this approach, we deter-
mined that coronary endothelial cells require BMPER to migrate.
Cells isolated from BMPER/ ventricles migrated less than their
wild-type counterparts, and the subsequent observations of
shorter chains and less branching may be directly caused by this
impairment. Interestingly, though, BMPER is not expressed in the
coronary endothelial cells as the coronary arteries connect with
the aorta (Fig. 1G and H), suggesting that BMPER plays an earlier
role in the endothelial cell that promotes migration. This early role
Fig. 6. BMPER indirectly promotes ventricular endothelial cell migration. (A, B) Wild-type and BMPER / E13.5 hearts were cultured ex vivo with vehichle control- or
BMPER-conjugated beads. (A) Smad phosphorylation was assessed after 24 h of culture. pSmad signaling intensity was stronger in the cells adjacent to BMPER-conjugated
beads compared with control beads and was similarly stronger in wild-type compared with BMPER/ hearts. (B) Endothelial migration was also assessed after 24 h of
culture using the endothelial marker PECAM. PECAM-positive vessels were more closely associated with BMPER-conjugated beads than with control beads. The small
number of BMPER/ hearts cultured with control beads precluded statistical analyses in this experiment. n¼6 wild-typeþcontrol bead, 9 wild-typeþBMPER bead,
2 BMPER/þcontrol bead, 4 BMPER/þBMPER bead. Scale bars, 120 μm. (C, D) Isolated wild-type endothelial cells (E13.5–16.5) were subjected to transwell migration
assays using (C) VEGF (25 ng/ml) and its vehicle control (0.1% BSA in 4 mM HCl) and (D) BMPER and its vehicle control (0.5% BSA in PBS). As expected, VEGF induced a nearly
three-fold increase in migration compared with the vehicle control. In contrast, a low dose of BMPER (10 ng/ml) induced endothelial migration (1.6-fold over the control
level of migration), whereas higher doses of BMPER (20–75 ng/ml) inhibited migration. npo0.05 vs. control; n¼3–7 transwells per condition.
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is supported by the in vitro coronary endothelial migration data.
However, we believe that BMPER also has an indirect role in this
process. The dose-dependent responses observed in the transwell
migration assays suggest that wild-type coronary endothelial cells
migrate in response to a low dose of BMPER but then stop
migrating in response to high doses of BMPER. In the aortic valve,
BMPER may affect additional signaling pathways that enhance
coronary artery recruitment, leading to an even stronger effect
than observed in our transwell assays. These ﬁndings may explain
why coronary plexus formation can begin normally in the
BMPER/ ventricles but then remodels incorrectly, leading to
defects in coronary stem formation. In addition, these ﬁndings
may explain how the BMPER/ embryo exhibits both atretic
coronary stems, which may be due to a failure of the coronary
endothelial cells to migrate enough to reach the aorta and/or a
failure to detect the aortic valve, and high take-off coronary
arteries, which may represent a simple failure of the coronary
endothelial cells to detect the aortic valve. This hypothesis is
further supported by the BMPERþ/ embryo, which does not
display coronary artery anomalies (data not shown) despite
impaired endothelial cell migration (Fig. 5).
We have established that Smad-dependent BMP signaling is
upregulated in the aortic valves when the coronary arteries should
connect to the aorta and that BMPER is required for this activity.
Further, BMPER is required speciﬁcally within the coronary endothe-
lial cells and promotes migration and remodeling, as shown using
isolated embryonic coronary endothelial cells. This study opens up an
innovative tactic for examining coronary plexus formation and
remodeling and the intrinsic and extrinsic factors that regulate these
processes.
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